Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer

NCT05064085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor-positive Breast Cancer

Interventions

DRUG: Cemiplimab
DRUG: Capecitabine

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]